A Randomised Placebo‐Controlled Study to Evaluate the Efficacy and Safety of a Two‐Dose Topical Terbinafine and Betamethasone Gel for the Treatment of Yeast (Malassezia pachydermatis) Otitis Externa in Dogs
4 affiliations
- 1Dechra Veterinary Products BV Bladel the Netherlands
- 2Dechra Development LLC Boston Massachusetts USA
- 3Dechra Veterinary Products Deutschland GmbH Aulendorf Germany
- 4Vista Research, LLC Bath Maine USA
Abstract
Background: Otitis externa (OE) with Malassezia pachydermatis overgrowth with limited bacterial involvement is common in dogs. Treatment with products containing antibiotics is unnecessary and not consistent with judicious use of antimicrobials.
Objectives: To evaluate the efficacy and safety of an otic gel containing 1% terbinafine and 0.1% betamethasone acetate for the treatment of yeast‐predominant canine OE.
Animals: 239 privately owned dogs were enrolled.
Materials and Methods: Inclusion criteria were an otitis index score (OTIS3) of ≥ 6 and yeast‐predominance on ear swab cytological evaluation. Dogs received either the study product containing terbinafine and betamethasone (TBG) or placebo (saline) on Day (D) 0 and D7. Follow‐up visits were on D7, D14, D28 and D45. Clinical success was defined as an OTIS3 score ≤ 3 on D45. Overall clinical response (by the veterinary surgeon and owner) and yeast cytological count reduction also were assessed. Safety was evaluated based on clinical assessments, haematological and clinical chemical analysis, urinalysis and adverse events.
Results: The treatment success was significantly higher in the treated group compared to the placebo group (62.9% versus 20.0%, p < 0.0001). Dogs receiving TBG had a treatment response described as ‘excellent’ or ‘good’ by 61.9% and 71.1% of veterinary surgeons and owners, respectively. The safety evaluation demonstrated that the otic gel was safe.
Conclusions and Clinical Relevance: Efficacy and safety of an otic gel for the treatment of canine OE associated with Malassezia pachydermatis were demonstrated.
Related
- Acupuncture for older adults with dementia in residential care homes: an assessor-blinded, randomised controlled trial
- Standardised procalcitonin monitoring and antibiotic duration in community-acquired sepsis: a pragmatic randomised controlled trial
- Efficacy and Safety of a Novel Oil Pulling Oral Rinse for Teeth Whitening: A Double-Blind, Randomised, Placebo-Controlled Trial
- Effect of nursing care program on healthy lifestyle behaviours and quality of life in women with endometriosis: a randomised controlled trial
- Intraoperative intravenous lidocaine for analgesia after oral cancer surgery with free perforator flap reconstruction: a randomised controlled trial
BibTeX
@article{baks2026randomised,
title = {{A Randomised Placebo‐Controlled Study to Evaluate the Efficacy and Safety of a Two‐Dose Topical Terbinafine and Betamethasone Gel for the Treatment of Yeast (Malassezia pachydermatis) Otitis Externa in Dogs}},
author = {Zorica Zivkovic Baks and Hope Baird Heinz and Stephan Grundke and Caryn Thompson and Roberto Garcia},
journal = {Veterinary Dermatology},
year = {2026},
month = aug,
doi = {10.1111/vde.70113},
url = {https://doi.org/10.1111/vde.70113},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - A Randomised Placebo‐Controlled Study to Evaluate the Efficacy and Safety of a Two‐Dose Topical Terbinafine and Betamethasone Gel for the Treatment of Yeast (Malassezia pachydermatis) Otitis Externa in Dogs
AU - Zorica Zivkovic Baks
AU - Hope Baird Heinz
AU - Stephan Grundke
AU - Caryn Thompson
AU - Roberto Garcia
PY - 2026
DA - 2026/08/24
JO - Veterinary Dermatology
DO - 10.1111/vde.70113
UR - https://doi.org/10.1111/vde.70113
AB - Background: Otitis externa (OE) with Malassezia pachydermatis overgrowth with limited bacterial involvement is common in dogs. Treatment with products containing antibiotics is unnecessary and not consistent with judicious use of antimicrobials. Objectives: To evaluate the efficacy and safety of an otic gel containing 1% terbinafine and 0.1% betamethasone acetate for the treatment of yeast‐predominant canine OE. Animals: 239 privately owned dogs were enrolled. Materials and Methods: Inclusion criteria were an otitis index score (OTIS3) of ≥ 6 and yeast‐predominance on ear swab cytological evaluation. Dogs received either the study product containing terbinafine and betamethasone (TBG) or placebo (saline) on Day (D) 0 and D7. Follow‐up visits were on D7, D14, D28 and D45. Clinical success was defined as an OTIS3 score ≤ 3 on D45. Overall clinical response (by the veterinary surgeon and owner) and yeast cytological count reduction also were assessed. Safety was evaluated based on clinical assessments, haematological and clinical chemical analysis, urinalysis and adverse events. Results: The treatment success was significantly higher in the treated group compared to the placebo group (62.9% versus 20.0%, p < 0.0001). Dogs receiving TBG had a treatment response described as ‘excellent’ or ‘good’ by 61.9% and 71.1% of veterinary surgeons and owners, respectively. The safety evaluation demonstrated that the otic gel was safe. Conclusions and Clinical Relevance: Efficacy and safety of an otic gel for the treatment of canine OE associated with Malassezia pachydermatis were demonstrated.
SN - 0959-4493
SN - 1365-3164
ER -